Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Phase IIb trials of tuberculosis therapy rely on early biomarkers of treatment effect. Despite limited predictive ability for clinical outcomes, culture conversion, the event in which an individual previously culture positive for Mycobacterium tuberculosis yields a negative culture after initiating treatment, is a commonly used endpoint. Lack of consensus on how to define the outcome and corresponding measure of treatment effect complicates interpretation and limits between-trial comparisons. We review common analytic approaches to measuring treatment effect and introduce difference in restricted mean survival times as an alternative to identify faster times to culture conversion and express magnitude of effect on the time scale. Findings from the PanACEA MAMS-TB trial are reanalyzed as an illustrative example. In a systematic review we demonstrate variability in analytic approaches, sampling strategies, and outcome definitions in phase IIb tuberculosis trials. Harmonization would allow for larger meta-analyses and may help expedite advancement of new tuberculosis therapeutics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664460 | PMC |
| http://dx.doi.org/10.1093/cid/ciab576 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Halal Perspectives on Grasshoppers (Locusts): A Path to Sustainable and Nutritionally Acceptable Alternative Protein Source.
Compr Rev Food Sci Food Saf
September 2025
Halal Products Research Institute, Universiti Putra Malaysia, Serdang, Malaysia.
The food system is under increased pressure because of the need for sustainability, greater food safety, and increasing need for protein sources. Grasshopper-based food products are becoming a new option. Products made from grasshoppers represent a sustainable and nutritious alternative to traditional livestock.
View Article and Find Full Text PDFA thermostable Cas9-based genome editing system for thermophilic acetogenic bacterium .
Appl Environ Microbiol
September 2025
Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang, Jiangsu, PR China.
is a thermophilic acetogenic bacterium capable of thriving at elevated temperatures up to 66°C. It metabolizes carbohydrates such as glucose, mannose, and fructose and can also grow lithotrophically utilizing hydrogen (H) and carbon dioxide (CO) or carbon monoxide (CO), with acetate serving as its main product. A simple and efficient genome editing system for would not only facilitate the understanding of the physiological function of enzymes involved in energy and carbon metabolism but also enable metabolic engineering.
View Article and Find Full Text PDFThe contribution of biophysical and biochemical CO concentration mechanisms to the carbon fixation of the green macroalga .
Mar Life Sci Technol
August 2025
State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai, 200241 China.
Unlabelled: CO concentration mechanisms (CCMs) are important in maintaining the high efficiency of photosynthesis of marine algae. Aquatic photoautotrophs have two types of CCMs: biophysical CCMs, based on the conversion of inorganic carbon, and biochemical CCMs, based on the formation of C acid intermediates. However, the contribution of biophysical and biochemical CCMs to algal carbon fixation remains unclear.
View Article and Find Full Text PDFA strain of mycovirus AaVV1 mediates hypovirulence of Alternaria species.
Pestic Biochem Physiol
November 2025
Hunan Provincial Key Laboratory for Biology and Control of Plant Diseases and Insect Pests, Hunan Agricultural University, Nongda Road 1, Furong District, Changsha City, Hunan Province 410128, PR China. Electronic address:
The genus Alternaria comprises a wide range of ubiquitous plant pathogens that affect various host plants. Certain mycoviruses can induce changes in the biological characteristics and virulence of host fungi, offering potential for biocontrol in managing fungal plant diseases. Here, we identified a mycovirus with a high degree of homology to Alternaria arborescens victorivirus 1 (AaVV1), which was previously reported from Alternaria arborescens, in the QRH strain of the heterologous host Alternaria gomphrenae.
View Article and Find Full Text PDFA 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
Lancet Infect Dis
September 2025
The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Background: Based on results from preclinical and clinical studies, a five-drug combination of isoniazid, rifapentine, pyrazinamide, ethambutol, and clofazimine was identified with treatment shortening potential for drug-susceptible tuberculosis; the Clo-Fast trial aimed to determine the efficacy and safety of this regimen. We compared 3 months of isoniazid, rifapentine, pyrazinamide, ethambutol, and clofazimine, administered with a clofazimine loading dose, to the standard 6 month regimen of isoniazid, rifampicin, pyrazinamide, and ethambutol in drug-susceptible tuberculosis.
Methods: Clo-Fast was a phase 2c open-label trial recruiting participants at six sites in five countries.